BioWorld BioWorld MedTech BioWorld Asia BioWorld Science

BioWorld

Peptidream, Genentech ink $1B deal for peptide-radioisotope drug conjugates
Peptidream Inc. and Genentech Inc., a Roche Holding company, signed a deal worth up to $1 billion to discover and develop macrocyclic peptide-radioisotope (peptide-RI) drug...

More in BioWorld

BioWorld MedTech

CMR Surgical rakes in $165M to hit $1B in funding
CMR Surgical Ltd. raised $165 million in financing from its existing investors that will allow the company to continue to innovate its portable robotic surgery system,...

More in BioWorld MedTech

BioWorld Science

Kidney disease culprit D2D3 also attacks pancreas
The contribution of the soluble form of urokinase-type plasminogen activator receptor (suPAR) as a risk factor for chronic kidney diseases (CKD) is well known. Researchers...

More in BioWorld Science

BioWorld Asia

Starpharma’s dendrimer platform delivers impressive results in bowel, ovarian cancer
Starpharma Holdings Ltd.'s nanoscale drug delivery technology shows enhanced safety and durable responses in phase II trials compared to standard of care therapies in...

More in BioWorld Asia

BioWorld Insider Podcast

Google’s Scott Penberthy joins the podcast for a visionary discussion that scans the horizon for startling changes artificial intelligence will bring to drug development in the relatively near future.